Journal
HUMAN VACCINES & IMMUNOTHERAPEUTICS
Volume 17, Issue 10, Pages 3276-3280Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/21645515.2021.1945901
Keywords
Clinical trial; COVID-19; vaccine; lanscape
Categories
Funding
- Chinese Academy of Medical Sciences' Initiative for Innovative Medicine [2020-I2M-2-007]
Ask authors/readers for more resources
This review depicts the current landscape of global COVID-19 vaccine research and development, summarizing key characteristics and available evidence on authorized vaccines for emergency use. It aims to provide insights for stakeholders to improve coordination in responding to the COVID-19 outbreak.
The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has affected billions of lives globally, and the world hopes to end this epidemic by effective vaccination. In this review, we depict the latest panorama of global COVID-19 vaccine research and development based on different technology platforms, and summarize key characteristics and available evidence on vaccines authorized for emergency use, in order to provide insights into improve coordination in the COVID-19 outbreak response for related stakeholders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available